Study may facilitate the development of new personalized treatments for schizophrenia An International Study Publi…

FHS
May 31, 2024
2:54 am

An international study led by the Hospital del Mar Medical Research Institute, in collaboration with researchers from the Neuropsychopharmacology Group at the University of the Basque Country (UPV/EHU) and researchers from the CIBER of Mental Health (CIBERSAM), and published in Nature Communications, may facilitate the creation of new personalized treatments for people diagnosed with schizophrenia.

Phase 1 trial for EBC-129 progresses into dose expansion

The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, is pleased to announce that the Phase 1 trial for EBC-129

May 24, 2024

Senate Finance Committee unanimously advances PBM, Medicare Part D reforms

The Senate Finance Committee on Wednesday advanced a package of bills that sets out to lower drug costs for Medicare and Medicaid beneficiaries, including reforms

November 9, 2023

Republican Senators Blast Biden’s Proposed HHS Budget

Republican and Democratic senators clashed over the Biden administration’s record on lowering drug prices during a Senate Finance Committee hearing on Thursday centered on the

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.